Clinical trial
Allogeneic Blood Stem Cell Transplantation
NCT00423709 · M.D. Anderson Cancer Center, Other · Completed
Key facts
| NCT number | NCT00423709 |
|---|---|
| Title | Allogeneic Blood Stem Cell Transplantation |
| Official title | A Study of Allogeneic Blood Stem Cell Transplantation With Purine Analog-Based Conditioning For Patients With Advanced Hodgkin's Disease |
| Lead sponsor | M.D. Anderson Cancer Center, Other |
| Status | Completed |
| Study type | Interventional |
| Conditions | Hodgkin's Disease |
| Intervention type | Drug, Procedure |
| Interventions | Allogeneic Blood Stem Cell Transplantation, Fludarabine, Melphalan |
| Enrollment | 46 |
| Start date | Jan 1, 1998 |
| Primary completion | Aug 1, 2007 |
| Completion | Aug 1, 2007 |
| First posted | Jan 18, 2007 |
| Last update posted | Jan 24, 2012 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: